Marshall Wace North America’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-90,890
| Closed | -$7.26M | – | 1966 |
|
|
2021
Q1 | $7.26M | Buy |
90,890
+68,419
| +304% | +$5.34M | 0.03% | 466 |
|
|
2020
Q4 | $1.77M | Sell |
22,471
-16,146
| -42% | -$947K | 0.01% | 785 |
|
|
2020
Q3 | $1.7M | Buy |
+38,617
| New | +$1.9M | 0.01% | 638 |
|
|
2020
Q2 | – | Sell |
-3,308
| Closed | -$119K | – | 1611 |
|
|
2020
Q1 | $119K | Buy |
+3,308
| New | +$188K | ﹤0.01% | 973 |
|
|
2019
Q4 | – | Sell |
-1,832
| Closed | -$137K | – | 1730 |
|
|
2019
Q3 | $137K | Sell |
1,832
-1,068
| -37% | -$90.5K | ﹤0.01% | 1013 |
|
|
2019
Q2 | $234K | Buy |
2,900
+2,336
| +414% | +$164K | ﹤0.01% | 1014 |
|
|
2019
Q1 | $38K | Sell |
564
-21,481
| -97% | -$1.63M | ﹤0.01% | 1309 |
|
|
2018
Q4 | $1.64M | Buy |
22,045
+15,651
| +245% | +$1.29M | 0.02% | 475 |
|
|
2018
Q3 | $589K | Buy |
+6,394
| New | +$609K | ﹤0.01% | 684 |
|
|
2018
Q2 | – | Sell |
-10,236
| Closed | -$1.14M | – | 1844 |
|
|
2018
Q1 | $1.14M | Buy |
+10,236
| New | +$1.15M | 0.01% | 966 |
|
|
2017
Q3 | – | Sell |
-59,696
| Closed | -$4.66M | – | 1605 |
|
|
2017
Q2 | $4.66M | Buy |
59,696
+26,171
| +78% | +$1.97M | 0.03% | 522 |
|
|
2017
Q1 | $2.68M | Buy |
+33,525
| New | +$2.66M | 0.02% | 518 |
|
Marshall Wace North America's CMD Position: Q2 2021 in Review
Marshall Wace North America sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 90,890 shares — an estimated $7.26M sold.
Marshall Wace North America first reported a position in CMD in Q1 2017 and held it in 12 quarters. The position peaked at $7.26M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Marshall Wace North America reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Marshall Wace North America sold 90,890 Cantel Medical Corporation shares in Q2 2021, an estimated $7.26M.
- Marshall Wace North America first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 12 quarters.
- Marshall Wace North America's Cantel Medical Corporation position peaked at $7.26M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.